United States Interventional Neurology Devices Market 2033 | Growth Drivers, Key Players & Investment Opportunities

Market Size and Growth

The global interventional neurology devices market size reached US$ 2.31 Billion in 2024 from US$ 2.18 Billion in 2023 and is expected to reach US$ 4.11 Billion by 2033, growing at a CAGR of 6.7% during the forecast period 2025-2033.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/interventional-neurology-devices-market?sb

Key Development:

United States: Recent Interventional Neurology Devices Developments

✅ In December 2025, Bendit Technologies received US FDA 510(k) clearance for its Bendit17 steerable microcatheter, described as the smallest steerable microcatheter on the market and designed to improve precision in complex vascular procedures, with first clinical use planned for early 2026.

✅ In late 2025, the U.S. interventional‐neurology market continued strong activity with ongoing portfolio updates from Penumbra's computer‐assisted vacuum thrombectomy (CAVT) platform, reflecting intensified competition in thrombectomy devices and continuous clinical data presentations.

✅ In 2025, FDA granted 510(k) clearance to Imperative Care's large‐bore thrombectomy catheter extensions (Zoom system), broadening mechanical thrombectomy options for acute ischemic stroke treatments.

✅ In early‐2025, Stryker completed its acquisition of Inari Medical, expanding Stryker's neuro/peripheral vascular portfolio a major strategic move in the interventional‐neurology device space.

Europe: Recent Interventional Neurology Devices Developments

✅ In December 2025, Penumbra secured CE‐mark approvals for its next‐generation Lightning Bolt 12 and Lightning Bolt 6X with TraX devices, offering faster clot removal performance and improved access to smaller vessels.

✅ In 2025, European investment activity included €50 million growth capital into German neurovascular device maker Acandis, aimed at supporting R&D and clinical expansion.

✅ Throughout 2025, several European device innovators (e.g., Acandis & phenox) expanded clinical trials and investigator‐led studies, advancing thrombectomy, stent, and coil technologies across neurovascular procedures.

✅ In 2025, the pRESET Delta thrombectomy device from phenox (Europe‐origin) progressed through U.S. regulatory pathways highlighting European device makers extending their global footprint.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=interventional-neurology-devices-market

Japan: Interventional Neurology Devices Developments

✅ In March 2025, Japan Stryker expanded the Trevo Retriever approval to extend its use for acute ischemic stroke treatment up to 24 hours after onset, making it the first device in Japan with this widened indication for mechanical thrombectomy. It broadens access to timely intervention for more stroke patients.

✅ In January 2025, Boston Scientific Japan launched the SENTINELTM Cerebral Protection System for transcatheter aortic valve implantation (TAVI) procedures - the first cerebral‐embolism protection device approved in Japan to help capture and remove embolic debris during high‐risk interventions.

Key Players:

=> Medtronic, Stryker, Johnson & Johnson, Penumbra, Inc., Terumo Corporation, Boston Scientific Corporation, MicroPort Scientific Corporation, and Acandis GmbH, among others.

Key Segments:

By Device Type

Neurovascular Stents - ~30% share, widely used in ischemic stroke and carotid stenosis interventions.
Embolic Coils - ~25% share, primary devices for cerebral aneurysms and arteriovenous malformations.
Aspiration Catheters - ~15% share, used in mechanical thrombectomy for acute ischemic strokes.
Microcatheters and Guidewires - ~15% share, essential for navigating complex neurovascular anatomy.
Balloon Catheters - ~10% share, applied in angioplasty and vessel dilation procedures.
Others - ~5% share, including flow diverters, detachable stents, and emerging minimally invasive devices.

By Indication

Ischemic Stroke - ~35% share, largest segment due to high incidence and procedural demand.
Hemorrhagic Stroke - ~10% share, devices focused on aneurysm repair and intracranial hemorrhage management.
Cerebral Aneurysm - ~25% share, driven by embolic coils, stents, and flow diverters.
Arteriovenous Malformation (AVM) - ~10% share, intervention devices for complex vascular malformations.
Carotid/Extra-Cranial Stenosis - ~15% share, demand from stent-assisted angioplasty procedures.
Others - ~5% share, including rare neurovascular disorders requiring specialized devices.

By End-User

Hospitals - ~50% share, primary adopters due to high procedure volumes and advanced neurointerventional suites.
Specialty Clinics - ~20% share, focused on high-precision neurovascular interventions.
Ambulatory Surgical Centers (ASCs) - ~15% share, growing adoption for minimally invasive neuro procedures.
Others - ~15% share, including research centers and academic hospitals performing clinical trials.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/interventional-neurology-devices-market?sb

By Region

North America - ~40% Share
Dominated by advanced healthcare infrastructure, neurointerventional expertise, and reimbursement support.

Europe - ~25% Share
Strong hospital networks and adoption of minimally invasive neurovascular therapies.

Asia-Pacific - ~20% Share
Rapid growth in emerging markets, increasing access to neurovascular devices and stroke interventions.

South America - ~10% Share
Growing adoption in tertiary hospitals and specialty centers.

Middle East & Africa - ~5% Share
Early-stage adoption in specialized hospitals and urban centers.

FAQ

What is the current size of the Interventional neurology devices Market?

A: In 2024, the Interventional neurology devices Market was valued at US$ 2.31 Billion , reflecting its strong industry presence.

Q2: How large is the Interventional neurology devices Market expected to be by 2033?

A: By 2033, industry forecasts suggest the Interventional neurology devices Market will grow to around US$ 4.11 Billion , demonstrating significant expansion.

Q3: What is the growth rate of the Interventional neurology devices Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 6.7% during the forecast period from 2025 to 2033.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.